(2005) Relationships among bacteria and systemic inflammation in COPD,

(2006) Wedzicha JA.Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease,

(2005) Airway and systemic inflammation and decline in lung function in patients With COPD,

(2004) Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD,

(2005) Local and systemic inflammation in chronic obstructive pulmonary disease,

(2004) Office spirometry significantly improves early detection of COPD in general practice,

(2005) Spirometry in the primary care setting:influence on clinical diagnosis and management of airflow obstruction,

(2001) Early detection in a high-risk population using spirometric screenig,

(2005) Attaining a correct diagnosis of COPD in general practice,

(2004) Effects of tiotropium on lung hyperinflation,dyspnoea and exercise tolerance in COPD,

(2006) The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease,

(2005) Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD,

(2005) Comparison of tiotropium once daily,formoterol twice daily and both combined once daily in patients with COPD,

(2006) Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD,

(2004) Early therapy improves outcomes of exacervations of chronic obstructive pulmonary disease,

(2005) Physiological changes during symptom recovery from moderate exacerbations of COPD,

(2005) Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease,

(2005) Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator,

(2006) The effect of tiotropium on exacerbations and airflow in patients with COPD,

(2006) Chronic obstructive pulmonary disease from unjustified nihilism to evidence-based optimism,

(2006) COPD:a common disease that is preventable and treatable,

(2005) One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium,

(2005) COPD:current therapeutic interventions and future approaches,

(2005) Treatment of COPD exacerbations:antibiotics,

(2004) How do viral infections predispose patients to bacterial infections,

(2006) Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD,

(1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease,

(2004) Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease,

(2005) Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease,

(2005) Treatment of COPD exacerbations:antibiotics,

(2004) Bacteria in exacerbations of chronic obstructive pulmonary disease,

(2002) A comparison of gemifloxacin and clrithromycin in acute exacerbations of chronic bronchitis and lung-term clinical outcomes,

(2004) Short-term and long-term outcomes of moxifloxcin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis,

(2005) Appropriate outpatient treatment of acute bacterial exacerbation of chronic bronchitis,

(2005) Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease,

(2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease,

(2005) A multidimensional grading system(BODE Index)as predictor of hospitalization for COPD,

(2005) Pulmonary rehabilitation and the BODE index in COPD,